Member Info for Davius

That was my point, no big sales to show any profit taking, and if Lupupa's calculations are correct then there were more buys than sells today. If the trade figures are accurate then there were more buys than sells since the share price peaked around 25p this afternoon, including two buys totalling 3.8m shares. It has to be MMs doing this to the SP. The opening price tomorrow will probably indicate what's going on to some extent. I'm not a holder in this stock at present, and have no vested interest either way.

I've not seen any RNS on a bid, so presumably the SP shooting up is purely on speculation? If so then either it goes back up when a bid is announced or we see 14p or less again fairly soon. Can't see any share trades to explain why it dropped so swiftly in the last half hour or so today, so I would suspect, as someone suggested, this was a market makers movement. However, I am not convinced the MMs would do this to the price if they thought a bid was forthcoming, more it would be because they thought it wasn't.

Slightly surprised at these, sold at 56p purely for overstocking reasons, thought they might pause before continuing up. However the slide has gone on for a couple of days now, so not sure at what level to buy back in...

The consolidation does not affect the market valuation of the company, only the number of shares and the price paid for them. I've not seen the terms, but if as mentioned in a previous posting they consolidate 100 1p shares into a £1 share that does not mean the share price of the new shares will be £1, just their nominal value and the number in circulation changes. In the teamonster example, the 100000 shares bought at £2000.00 (2p each) will consolidate into 1000 shares worth £2000.00 (£2.00 each), the value your holding will be unaffected.

If the nominal value of a share is 2p and they consolidate 1 for a hundred then the nominal value of the shares becomes £2, or they may choose to change that value. Whatever, it has no real bearing on the share price, which if currently at say 2.2p, would become £2.20. The value of your shareholding would remain the same. As someone below commmented, it can make a company more appealing to institutions who often tend to shy away from penny shares. Also market makers tend to mark a smaller spread on a higher share price in percentage terms. 2.1-2.2p currently might be 215-220p after consolidation for example.

...and am hanging on to MOB for the time being. Would have liked to have stayed into both, but today was the last day to sell TRX and not have to pay for then ;) and am a bit overextended. Will be back in if the price happens to drop off.

I'm setting a target of 60p. I think this is the one to hold on to, although MOB had recovered a tad this morning but still low. I suspect the 88p suggested by a broker is a bit on the high side in the short term at least, but the P/E Ratio of 4.32 is ridiculously low. I have little doubt it's the level of debt keeping the share price subdued.

A harsh reality of small companies is that when a major customer buggers off then they have serious problems. Yesterdays announcement by Ordnance Survey that they are ditching the software produced by Tadpole in December pretty much halved the value of the company. TAD went from being a 'ticking along nicely' to 'potential recovery stock' in a heartbeat. Postings have been few and far between and generally negative. Have to agree with that analysis unfortunately. One to avoid for now.

Makes my buy recommendation at 61p a bit misguided. As I'm a bit overextended I need to decide whether to sell TRX or MOB. Send in your votes on a postcard...

Of my two recent holdings TRX is ticking up nicely and MOB took a pasting late on today. I think TRX has some way to go yet, although sitting on a net 20% after costs and still able to sell as a closing trade is tempting. However I think I'd be more tempted to ditch MOB and stay with TRX. Will have to juggle the numbers in the morning...

The Times this morning comments on yesterdays rise being partly because of the director buys but also on a broker recommendation to buy with an 88p target price. A definite hold (or buy if you don't currently have any) I'd say.

TRX Creeping up after this mornings announcements. Lots of buying, anyone in as late as last Friday is doing well.

Assuming the update is GMT then it's on for 0700 Monday morning UK time, so be ready when the markets open. SP creeping up again today, quite a lot of buying going on.

Huge problems at Isoft, their software system for the NHS is hugely over budget and late. Reported an expected 10-15% revenue slump a month or two back, have had director resignations, investigations into it's auditors and it lost £382m in the last financial year, on turnover of £201m. Could be seen as a recovery stock if they get the NHS sorted, but I for one would want to see the share price collapse halted before I considered this a worthy risk. I'd suggest it's worth taking a look at TRX, formerly part of IOT, instead.

The recent small rise has been reported in the press as due to the update next week expected to be favourable. The updated is due on Monday 13th. I would expect the SP to increase a little before then and then open higher/lower on Monday depending on the news.

Yes, I did get in, 7000 shares at 42.4p on Friday. Showing a gain but not by much, SP backed off a little today on some moderate selling. I think it has potential and certainly deserves to be higher.

Further progress on TRX this morning. No new RNS but plenty of buys coming in. Suspect the rumour mill is at work again regarding takeover. Watch this space.

Well, you never can tell just when a company is going to release bad news. It opened at 34p so has recovered a tad. Definitely one for the long term. Pain to see such a fall, but such is the way with pharma stocks. Pending any further agreements the next trading statement will be in a month, I don't expect much movement in the SP until then at least.

£11.95 commission, on line trading. I use them and they've been ok. Buy/Sell only, no advice. http://www.tdwaterhouse.co.uk/

Despite the debts TRX looks to be a good potential buy, being the 'best bits' of ISoft. Decent balance sheet, £223m net asset value and pays dividends. Low SP and bid interest, had to start rising sooner or later.